Literature DB >> 16860568

Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity.

Koichiro Yasuda1, Tetsuro Matsunaga, Tetsuya Adachi, Norihiko Aoki, Gozoh Tsujimoto, Kinsuke Tsuda.   

Abstract

Adrenergic receptors (ARs) are cell-surface G-protein-coupled receptors for catecholamines. They are essential components of the sympathetic nervous system, organized within the autonomic nervous system (ANS), which controls various physiological functions, including energy homeostasis and metabolism of glucose and lipids. An impairment of ANS function in metabolism is considered to be one of the pathological states associated with human obesity and related metabolic diseases; thus, alterations in AR function might be implicated in the pathophysiology of these diseases. Several studies have suggested an association between obesity phenotypes and some AR polymorphisms. In vitro and human clinical studies indicate that some of these polymorphisms have functional and pathophysiological significance, including the linkage to ANS function. This review summarizes present knowledge of AR polymorphisms related to human obesity, and their association with ANS function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860568     DOI: 10.1016/j.tem.2006.07.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  8 in total

Review 1.  Pharmacogenetics as a tool to tailor antiretroviral therapy: A review.

Authors:  Antonio Aceti; Laura Gianserra; Lara Lambiase; Alfredo Pennica; Elisabetta Teti
Journal:  World J Virol       Date:  2015-08-12

2.  Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population.

Authors:  Tetsuro Matsunaga; Koichiro Yasuda; Tetsuya Adachi; Ning Gu; Tsubasa Yamamura; Toshio Moritani; Gozoh Tsujimoto; Kinsuke Tsuda
Journal:  J Hum Genet       Date:  2006-10-31       Impact factor: 3.172

3.  Vagal nerve function in obesity: therapeutic implications.

Authors:  John G Kral; Wencesley Paez; Bruce M Wolfe
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

4.  Systemic factors associated with intraocular pressure among subjects in a health examination program in Japan.

Authors:  Satsuki Takahashi; Katsunori Hara; Ichiya Sano; Keiichi Onoda; Atsushi Nagai; Shuhei Yamaguchi; Masaki Tanito
Journal:  PLoS One       Date:  2020-06-03       Impact factor: 3.240

5.  Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies.

Authors:  Fabio Panariello; Vincenzo De Luca; Andrea de Bartolomeis
Journal:  Schizophr Res Treatment       Date:  2010-12-06

6.  Metabolic syndrome as a risk factor for elevated intraocular pressure.

Authors:  Nedime Sahinoglu-Keskek; Sakir Ozgur Keskek; Selim Cevher; Sinan Kirim; Asim Kayiklik; Gulay Ortoglu; Tayyibe Saler
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

7.  Evaluation of Association of ADRA2A rs553668 and ACE I/D Gene Polymorphisms with Obesity Traits in the Setapak Population, Malaysia.

Authors:  Vicneswari Shunmugam; Yee-How Say
Journal:  Iran Red Crescent Med J       Date:  2016-02-13       Impact factor: 0.611

8.  Common and Unique Genetic Background between Attention-Deficit/Hyperactivity Disorder and Excessive Body Weight.

Authors:  Monika Dmitrzak-Weglarz; Elzbieta Paszynska; Karolina Bilska; Paula Szczesniewska; Ewa Bryl; Joanna Duda; Agata Dutkiewicz; Marta Tyszkiewicz-Nwafor; Piotr Czerski; Tomasz Hanc; Agnieszka Slopien
Journal:  Genes (Basel)       Date:  2021-09-13       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.